The Project BioShield Act of 2004 (P.L. 108-276) established a 10-year program to acquire civilian medical countermeasures to chemical, biological,radiological, and nuclear (CBRN) agents for the Strategic National Stockpile.Provisions of this act were designed to encourage private companies to develop these countermeasures by guaranteeing a government market for successfully developed countermeasures… This report discusses actions taken by Congress and the Administration that have affected this program, describes the decision-making process for choosing countermeasures, describes the countermeasures for which the Department of Health and Human Services (HHS) has contracted, and discusses accounting discrepancies in Project BioShield budget documents. This report will be updated periodically.
Project BioShield: Appropriations, Acquisitions, and Policy Implementation Issues for Congress
- April 7, 2011
- | Filed under North America, Report, and 2001-2025
